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During cell differentiation epigenetic processes permit the establishment of a cell type speciﬁc tran-
scriptome by limiting the fraction of the genome that will be expressed. Based upon steady-state
requirements and transcription factor expression, differentiated cells respond transiently to exter-
nal cues by modulating the expression levels of subsets of genes. Increasing evidence demonstrates
that the genome is organized non-randomly in a hierarchy of structures within the nuclear space,
where chromosome territories are segmented into Topologically Associating Domains (TADs) and
sub-domains. It remains poorly understood how this three-dimensional organization of the genome
participates in the acquisition of a cell-speciﬁc program of gene expression. Furthermore, it is
unknown whether this spatial framework inﬂuences the dynamic changes of gene expression that
accompany alterations in the cell environment. In this review, we will discuss the impact of genome
topology on the response of breast cancer cells to steroid hormones. We will cover steroid nuclear
receptor mechanisms of action and discuss how topological organization of the genome, including
segmentation into TADs, acts as a combinatorial platform to integrate signals whilst ultimately
ensuring coordinate regulation of gene expression.
 2015 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
During the process of cell differentiation epigenetic mecha-
nisms allow the establishment of a chromatin landscape that
ensures the gene expression pattern required for speciﬁc cellular
functions: maintenance of expression of house-keeping genes,
silencing of genes non-related to the tissue function, activation
or pausing of the cognate tissue gene network. This is accom-
plished by active silencing of genes that should not be expressed
in a given cell type or, conversely, by maintaining in an accessible
conﬁguration genes that could be regulated in response to environ-
mental changes [1,2]. In terminally differentiated cells the basal
transcriptional network depends on the particular repertoire of
speciﬁc transcription factors expressed by the cell which also
determines the response to extracellular cues, for instance steroid
hormones. Steroid receptors are highly expressed in reproductive
tissues where they play essential roles in the signal transduction
of sexual hormones. In normal mammary epithelial cells estrogens
and Progestins exert pleiotropic effects to control the prolifera-
tion/differentiation balance and paradoxically act as etiologicdeterminants of breast cancer [3,4]. These hormones act through
binding to their cognate receptors and can activate or repress the
expression of thousands of genes in breast cancer cells. Hormone
activated receptors can bind directly to the promoter of the target
genes, where they orchestrate the recruitment of chromatin
remodeling activities and of the general transcription machinery
[5–7]. The precise mechanisms of action have been described for
several responsive genes but the development of
high-throughput sequencing technologies recently provided a
more global vision. Indeed, genome-wide analysis of nuclear recep-
tor binding by ChIP-Seq has shown a striking absence of direct
binding of the receptors within the proximal promoter region of
most responsive genes. In contrast, the major regulatory sites
bound by hormone receptors behave as enhancers and exert their
actions at distance from the responsive promoters [8–10]. These
observations suggest an important role of the three-dimensional
(3D) organization of the genome in hormonal gene regulation.
It is becoming increasingly more evident that chromosomes and
genes are non-randomly positioned in the cell nucleus and the
vision of a dynamic and complex organization of the nucleus is
replacing the classical view of genomes as linear sequences.
Therefore, a proper understanding of cell identity and behavior
requires the 3D integration of nucleotide sequence information
and the epigenetic states of chromatin within the nuclear space
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ries within the cell nucleus and more recently the partitioning of
the eukaryotic chromosomes in so-called Topologically
Associating Domains (TAD) has been revealed [13–15]. The bound-
aries between TADs appear to be common between cells of differ-
ent origins, suggesting that they offer a modular structural scaffold
for coordination of the processing of the genetic information, nota-
bly transcription [13,16]. Changes in the levels of expression of
genes appear to be correlated within TADs during cell differentia-
tion, potentially by topologically constraining the activity of
enhancers or silencers [14,17]. Those structures also play impor-
tant roles in the dynamic response of differentiated cells in
response to external cues [18,19]. In this review we will discuss
the mechanisms of action of steroid hormone receptors in the con-
text of the three-dimensional organization of the nuclear genome,
focusing on the role of TADs in the coordination of transient gene
expression changes induced by steroid hormones.2. Modulation of gene expression by steroid hormones
2.1. Transcriptional modulation by steroid hormones
Steroids hormones, e.g. Progestins, Estrogens (notably Estradiol,
E2) and Glucocorticoids, exert pleiotropic actions on a wide vari-
ety of tissues by modifying the expression of their target genes
at the transcriptional level. The expression of hundreds to thou-
sands of protein-coding genes is rapidly modiﬁed in breast cancer
cells in response to Progesterone or Estradiol. Microarrays and,
more recently, RNA-Seq experiments demonstrate that these hor-
mones can repress or activate gene transcription within 1–6 h of
hormone exposure [8,20,21]. Although some of those changes in
transcript levels depend on post-transcriptional modiﬁcations,
the development of GRO-Seq, which allows direct monitoring of
transcription rates, demonstrated an unexpected wide-spread
action of Estradiol in MCF-7 cells [22]. Up to 30% of transcripts
expressed in these cells are affected by hormone, the majority of
which with changes detected as early as 40 min after exposure.
Those changes have been shown to concern protein coding tran-
scripts as well as non-coding RNA and previously unannotated
transcripts [22]. More generally, differential expression analyses
suggest that these hormones can affect transiently the transcrip-
tion of approximately 10–15% of expressed protein coding genes,
corresponding to thousands of genes. Interestingly, many respon-
sive genes are not randomly located throughout the linear genome
but are frequently found as co-regulated clusters, with repressed
and activated genes segregated within responsive domains
[18,21,23,24].
2.2. Steroid receptors
Steroids hormones are lipophilic molecules that mainly act
through binding to their cognate intra-cellular receptors, which
belong to the Nuclear Receptor super-family [6,7]. Nuclear
Receptors, such as the Estrogen, Progesterone and Glucocorticoid
Receptors (ER, PR and GR, respectively), act as ligand inducible
transcription factors which, upon activation by hormone ﬁxation
to their Ligand Binding Domain (LBD), can directly recognize speci-
ﬁc DNA sequences (so called Hormone Responsive Element, HRE)
via their DNA Binding Domain (DBD), or indirectly by interacting
with other sequence-speciﬁc transcription factors [6,7]. It has been
proposed that Nuclear Receptors bind preferentially in open chro-
matin domains that are classically seen as depleted of nucleosomes
[10]. However, in contrast, we observed that the Progesterone
Receptor binds preferentially to nucleosomally organized DNA
sequences where it initiates profound modiﬁcations of thechromatin ﬁber [8,25]. This is made possible as hormone binding
to Progesterone Receptor promotes crosstalk with kinase signaling
pathways, leading to the formation of complexes containing chro-
matin modifying enzymes that accompany the receptor to speciﬁc
regions of chromatin. Steroid hormones are known to activate var-
ious signaling cascades initiated by a small fraction of receptors
anchored at the plasma membrane [26–29]. The different kinases
activated through this so-called ‘‘non-genomic’’ pathway converge
with the activated receptors to chromatin where they exert essen-
tial roles in the post-translational modiﬁcation not only of the
receptor itself, but also of histone tails and potentially chromatin
remodeling complexes [29,30]. Indeed, once bound to their speciﬁc
HRE or targeted to chromatin through protein–protein interac-
tions, Nuclear Receptors orchestrate the recruitment of a plethora
of co-regulatory proteins, including enzymes that modify the
nucleosome core histone tails as well as ATP-dependent remodel-
ing complexes involved in nucleosome sliding or eviction [31]
which ultimately leads to modulation of the general transcription
machinery [5].
2.3. Combinatorial modiﬁcations of chromatin by steroid receptors
Hormone induced remodeling of promoters occur in promoter
speciﬁc and combinatorial manners. For example, the transcrip-
tional activation of the Mouse Mammary Tumor Virus (MMTV)
promoter by Progestins or Glucocorticoids requires the successive
and controlled recruitment of multiple enzymatic activities
[32,33]. In a ﬁrst cycle, which occurs within 2 min of Progestin
exposure, a NURF containing remodeling complex is recruited
along with Progesterone Receptor, the ASCOM methyl transferase
complex and the CDK2 protein kinase (Fig. 1). This ﬁrst wave leads
to the methylation of H3 on K4 and the displacement of an HP1c
containing repressive complex and the linker histone H1. This ﬁrst
step is followed by a second cycle of remodeling, which involves
the acetylation of H3K14 by the histone acetyl-transferase PCAF
that helps to anchor the BAF (SWI/SNF) ATP-dependent remodeling
complex, which, in turn, catalyzes the displacement of
H2A/H2B dimers [33,34]. The proper regulation of this
Progestin-responsive model gene also involves CDK2-dependent
phosphorylation and activation of PARP1, which synthesizes
Poly-ADP Ribose (PAR) thus contributing to additional modiﬁca-
tion of the chromatin structure [26]. Similar profound chromatin
remodeling and sequential recruitments of co-regulatory com-
plexes have been described for other gene models in response to
different steroids [32,35]. The nature and the combinations of the
different complexes required, as well as their kinetics of recruit-
ment, are highly promoter speciﬁc. Although this differential com-
binatorial recruitment may depend on the combinations of
responsive elements within the regulatory regions of different
genes, it also likely reﬂects differential requirements for remodel-
ing activities, depending on the chromatin state of the promoters
prior to hormone exposure [36].
2.4. Steroid receptors act through long-range chromatin interactions
Recent advances in the biology of steroid receptors suggest that
these direct effects on promoters are seen only in a small subset of
target genes. ChIP-Seq experiments unexpectedly showed that
Nuclear Receptor binding to chromatin occur also within gene bod-
ies and in inter-genic regions. In generals, Nuclear Receptors bind
to many sites located far away from the genes they regulate. This
is notably the case for the Estrogen, Progesterone and
Glucocorticoid Receptors, for which only around 10% of sites are
located at less than 5 kb of promoters. The number of binding sites
is an order of magnitude higher than the number of responsive
genes. However, a large proportion of the genes regulated by
Fig. 1. Progestins induce rapid and important changes in chromatin at and the level of the promoter of responsive genes. These events involve the combinatorial and
successive action of several remodeling complexes which leads to the displacement of repressive complexes, modiﬁcation of the chromatin structure by eviction of linker
histones and reorganization of nucleosomes.
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imal promoters [8–10]. Although it might reﬂect secondary or indi-
rect regulation of those genes, GRO-Seq experiments performed in
MCF-7 in response to Estradiol showed that around 50% of thetranscripts modiﬁed during the ﬁrst 40 min of treatment lacked
proximal ER binding sites [22]. In many cases the transcriptional
regulation of steroid target genes seems therefore to require the
action of regulatory sequences located further away from the
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performed using antibodies directed against the Estrogen
Receptor in MCF-7 cells revealed important networks of interac-
tions between Estrogen Receptor bound sites after 30 min of treat-
ment with Estradiol [37]. Thus it appears that a signiﬁcant fraction
of these distal binding sites engaged interactions with promoters,
suggesting they act as enhancers.
Traditionally, enhancers are viewed as sites where the recruit-
ment of transcription factors can promote transcription of target
genes located further away, either upstream or downstream.
Most of them have been shown to act through physical interactions
with the target promoters by chromatin looping [38]. Although
individual enhancers are well known regulators of speciﬁc genes,
the emergence of High Throughput methodologies, either
ChIP-Seq or Chromosome Conformation Capture (3C)-derived
methods [39], uncover a much more complex view. It appears that
enhancers not only act on the closest gene promoter, but are also
engaged in complex interaction networks with several promoters
and other enhancers [17,19]. These observations strongly suggest
that long-range regulation is an essential principle, shaping the
transcription landscape as well as its transient modiﬁcations in
response to changes in the cell environment. Recent analyses sug-
gest that the activity of enhancers and regulatory elements is
mainly restrained within sub-megabase scale domains corre-
sponding to Topologically Associating Domains (TADs) [13–
15,40,41].
3. TADs as modular units for gene expression
In mammals, TADs have been identiﬁed by 5C and Hi-C exper-
iments as 1 Mb-sized domains of high local frequency of interac-
tions and separated from each other by sharp boundaries [13,14].
TAD borders are characterized by enriched loading of structural
proteins, like CCCTC-binding factor (CTCF) and cohesins, as well
as by a high density of actively and ubiquitously expressed genes
[13,40,42]. The location of TADs borders appear to be similar
between cell types since more than 70% of them are shared
between cells of different origins [13]. TADs appear to functionally
organize the genome. For example, they have been shown to corre-
spond to individual units of replication, which show cell speciﬁc
kinetics of replication timing [43]. In addition, some TADs overlap
with LADs (Lamina Associated Domains), domains of the genome
associated with the nuclear lamina that contain transcriptionally
inactive genes. TADs have also been shown to overlap with large
chromatin blocks enriched in repressive histone marks as
H3K9me3 or H3K27me3. In contrast, other TADs are characterized
by high transcriptional activity with most genes covered by his-
tone marks corresponding to an active state (e.g. H3K36me2/3)
[13,14,16]. Thus TADs tend to exhibit homogeneous chromatin
states, either active or repressive, which determine their associa-
tion to spatially segregated chromatin compartments [16,44].
TAD boundaries therefore limit the spreading of chromatin modiﬁ-
cations and separate domains with divergent degrees of permis-
siveness for transcription (see Fig. 2A). However, the epigenetic
signature of TADs does not seem to be determining factor for their
formation, since boundaries are maintained between TADs that
share similar chromatin states and, conversely, absence of
H3K9me3 domains in G9a deﬁcient mice does not lead to the dis-
appearance of the boundaries [14]. This suggests that TAD bound-
aries are important structural regions that do not depend on the
internal chromatin state but that are used to isolate genomic ele-
ments in a combinatorial way depending on the cell type. Indeed,
the epigenetic signature of TADs differs between cell types,suggesting a role of these structures in patterning the cell speciﬁc
chromatin landscape (Fig. 2A; [16]).
The relatively homogeneous chromatin state of a TAD likely
reﬂects the local enrichment of distinct chromatin remodeling
and histones modifying activities. Further cell speciﬁc mechanisms
will therefore establish the ﬁnal pattern of gene expression within
the global environment of each TAD. This is likely achieved by the
formation of speciﬁc loops that will either exclude genes or group
of genes from the general inﬂuence and/or attribute speciﬁc regu-
latory sequences to a given gene or group of genes. These
cell-speciﬁc loops may explain the formation of different
sub-TAD structures in different cell types (Fig. 2A and B). Indeed,
high resolution 3C-derived experiments have demonstrated that
TADs can be further internally compartmentalized in
sub-domains and loops, which boundaries might depend on differ-
ent insulators and regulatory proteins combinations [41,45].
Interestingly, these secondary boundaries are more dynamic and
differ between cell types. However, although they generate further
compartmentalization and speciﬁcity, it appears that these
sub-domains enter in contact more frequently with other
sub-domains within their own TAD, indicating that they do not
form totally independent structures (Fig. 2A and B). It is therefore
tempting to propose that TADs represent cell invariant structural
scaffolds that facilitate the formation of cell-speciﬁc functional
loops meanwhile they also limit the possible functional interac-
tions that could be engaged.
Intuitively, the property of TADs to be isolated from each other
makes plausible that the activity of enhancers could be restricted
to genes located within the same TAD. Indeed, most
enhancers/promoters loops observed genome-wide occur between
elements located within a single TAD [19,46,47] and as a conse-
quence the genes within a TAD frequently show correlation in their
activity [14,18,19]. However, the segmentation in TADs also allows
a precise and tunable action of intra-tads enhancers on genes
located close to the TAD boundaries, as it has been described for
the HOXD cluster [48].
TADs thus offer a modular scaffold to shape epigenetic domains.
By allowing changes in chromatin in a modular way during differ-
entiation, the segmentation of the genome in TADs might be essen-
tial to the proper patterning of gene expression [13,16]. Such a
view is interesting as the preferential location of house-keeping
genes close to the boundaries between TADs, a more permissive
area for transcription and common to various cell types, will favor
their ubiquitous expression [16,40]. Conversely, tissue-speciﬁc
genes, located further away from the TAD borders, will be more
prone to be inﬂuenced by the global chromatin state of the TAD.
The existence of regions with distinct permissivity for transcription
may contribute to and provide a topological scaffold to the fre-
quent coordinated expression observed throughout the genome
[49,50] as well as to the large scale changes in chromatin occurring
during differentiation [51,52] or during malignant transformation
[53,54].
The high frequency of contacts within TADs is probably reﬂect-
ing facilitated collisions as a consequence of both more focal speci-
ﬁc interactions between regulatory elements within domains and
insulation from neighboring region. Although this topological orga-
nization probably does not directly determine the transcription
level of the individual resident genes, it could globally inﬂuence
their expression by its relative permissiveness and accessibility
to regulatory proteins. This implies that different regulatory mech-
anisms would be required to dynamically modify gene expression
within different type of TADs in response to transient changes of
the cell environment.
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Fig. 2. (A) Example of TADs as deﬁned in T47D breast cancer cells (top). Purple lines indicate the TADs borders (deﬁned in these cells, [18]), which are similarly positioned in
other cell types (HUVEC and HMEC (middle and bottom respectively; [45]; http://www.aidenlab.org/juicebox/)). The borders separate chromatin domains with distinct
chromatin signatures and transcriptional activities as demonstrated by the relative enrichment in H3K9me3 and H3K36me2/3 (UCSC genome Browser view of ENCODE
Consortium data for H3K36me3 and H3K9me3 in HMEC and HUVEC (Bernstein – Broad Institute) as well as H3K36me2 and H3K9me3 in T47D cells; [18]). The epigenetic
signature and the relative enrichment in epigenetic marks of the different TAD differ between cell types in a combinatorial manner. Within the TADs further loops (dashed
lines) deﬁne subdomains, which are formed in a cell speciﬁc manner and harbor speciﬁc activity. Those sub-domains remain separated from the adjacent TADs and more
prone to enter in contact with the rest of the cell invariant TAD. This organization once established in a given cell type constrains the accessibility and activity of inducible
transcription factors, which could bind at high density in some speciﬁc TADs, as for example the Progesterone Receptor (PR) in T47D cells. (B) Schematic representation of the
combinatorial organization of TADs in different cell types. Blue circles represent cell type invariant TADs borders. Depending on the cell type, TADs belong to active (green) or
inactive compartment (red). Further internal cell speciﬁc loops are formed (green and red circles) that could lead to partial insulation of subdomains.
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4.1. Clustering of steroid responsive genes and large-scale response to
hormones
As for other transcription factors, the loops involving Steroid
Receptor bound enhancers are mostly restricted within TADs
[8,18,37,55]. In addition, Steroid receptors binding sites are fre-
quently found clustered or densely concentrated over large
domains of the genome corresponding to TADs ([9,18]; Fig. 2).
Steroid responsive genes are frequently found clustered in discrete
regions of the genome where the opposite response is absent lead-
ing to segregation of activated and repressed genes in distinct TADs
[18,21,23,24]. These responsive clusters correlate with high den-
sity of receptors binding sites within TADs [18]. Probably not all
sites are functional, however, they can also correspond to
super-enhancers that act coordinately on the expression of the sur-
rounding genes [56]. Although some of these binding events might
only reﬂect facilitated accessibility of dedicated chromatin hubs
[10,57], it is probable they cooperatively act on the regulation of
the neighboring genes, as shown by the complex interactions
between ER binding sites from ChiA-PET [18,37]. In addition to
the changes in chromatin described above, transcription of enhan-
cer RNA (eRNA) is also induced within the underlying bound
regions [58]. These epigenetic effects could therefore spread over
larger domains and might contribute to the coordinated regulation
of the neighboring genes [24,51,59]. Such large-scale coordination
of response is likely not restricted to steroid but may occur in
response to other signals [49].
The mechanisms by which steroid hormones lead to gene
repression are less understood and may involve distinct binding
kinetics of receptors as compared to activated genes [22].
However, hormone-repressed genes are also found clustered, sug-
gesting coordinated events occur within those regions. One could
hypothesize the existence of silencers that will act by recruiting
repressive co-regulatory proteins. Conversely, the repression ofthese genes could also be the consequence of a destabilization of
enhancers that were active prior to hormone exposure. This is sug-
gested by the observation that TADs enriched in negatively regu-
lated genes show a decrease in long-range interactions after
hormone exposure, whereas these interactions increase in TADs
activated by hormones [18].
4.2. Stable and dynamic contacts within TADs
Chromatin loops between enhancers and promoters are proba-
bly highly dynamic and an active enhancer might stochastically
contact with all genes located in its ﬁeld of action within its TAD.
In addition, the chromatin modiﬁcations that ﬁre at enhancers fol-
lowing the recruitment of remodeling complexes can also spread
over large distances, leading to large-scale modiﬁcations.
Obviously these events will contribute to coordinated changes in
gene expression and in the frequent transcription ripples observed
in response to various signals [49]. As mentioned, TADs and
sub-domains adopt preferential signatures depending on the cell
type. Once established, this organization will constrain the pattern
of gene expression and the response to external cues that may
require structural changes. Conversely, the changes in chromatin
that accompany modiﬁcations of transcription rate will affect the
possible changes in 3D organization of TADs. Recent high resolu-
tion Hi-C experiments in human primary ﬁbroblast showed that
regulatory loops between promoters and enhancers are found
within TADs prior to the binding of transcription factors activated
upon Tumor Necrosis Factor (TNF)-a exposure, suggesting that
pre-organized environment will favor the response to external
cues [19]. Indeed, the transcriptional response did not seem to
involve stimulus induced reorganization of the loci since the inter-
actions changes were limited after treatment with TNF [19].
Facilitated organization of domains was also observed in analysis
of the response to Glucocorticoid in mouse cells by 4C.
Glucocorticoid sensitive genes were organized in chromatin hubs
mainly stable before and after treatment [57]. Those hubs probably
reﬂect the TADs organization, as their boundaries have been shown
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and the strength of the interactions between genes were increased
upon treatment with the hormone in this case, suggesting a
dynamic consolidation of pre-settled domains [57]. In contrast,
3C experiments performed on other hormone responsive genes
suggested that the receptors are actively involved in generating
functional looping between distal regulatory sites and promoters
upon exposure to the hormone [8,37,60,61]. In addition, TADs
responding to Progestins also showed a dynamic redistribution of
internal interactions in correlation with the transcriptional
response of TADs [18].
Thus, although the existence of a preset organization seems to
be a common theme for gene response to external cues, the extent
of dynamic changes might depend on the type of stimulus and the
domains considered. Several non-mutually exclusive mechanisms
probably allow the regulatory interactions to occur (Fig. 3). It is
probable that, upon binding, the receptors might stabilize loops
that are favored by a more general topology of the domains: someFig. 3. Different models of dynamic reorganization of promoter/enhancer loops
upon steroid exposure within TADs. (A) In absence of hormone enhancer (blue
circle) and promoters are already found organized in networks of interactions.
Binding of the receptors (blue star) upon hormone exposure favor the recruitment
of coactivators without modifying the already established organization. (B)
Receptor binding to promoter(s) (green elements) and enhancer sites (blue circle)
upon hormone exposure is necessary to generate regulatory loops between the
regulatory elements. (C) The TAD is organized in a stochastic way where
interactions between enhancers and promoters are favored but remain highly
dynamic. Binding of the receptors within the region stabilized these interactions
either by tethering speciﬁc elements or modifying the chromatin ﬁber ﬂexibility.enhancer-promoter loops might be pre-settled prior to signal
exposure, either engaged by non-liganded receptors or additional
pioneer factors. Binding of the activated nuclear receptors within
this pre-organized conformation will lead to the recruitment of
additional co-regulatory factors leading to the stabilization of the
structure. Conversely, the binding of the receptors could precede
the formation of promoter-enhancer loops which are formed as a
consequence of the changes in chromatin ﬁber initiated at the sites
of binding (Fig. 3). Most of the effect of those distal enhancers
probably require looping to the promoter and the looping itself
depends on the activity of the receptor on chromatin (for example
by modifying the ﬂexibility of the chromatin), but other factors are
likely required for stabilizing those interactions. Known bridging
factors, CTCF or cohesins, may also be involved in the stabilization
of the loops, as altered expression of these factors leads to disreg-
ulation of genes in response to Estradiol [61–63].
5. Future directions
Depending on the chromatin state and the repertoire of tran-
scription factors in different cell types, TADs could respond differ-
ently to various signals and could therefore be considered as
transcriptional unit of response to external cues. This is supported
by the fact that genes within a given TAD are coordinately acti-
vated or repressed in response to distinct steroid hormones
(Fig. 4) [18].
One could hypothesize that the nature of the structural changes
that accompany the modiﬁcations in transcription will depend on
the general permissivity of the nuclear environment of TADs,
including their localization within the nuclear space. For instance,
due to the heterogeneous and frequently non-random distribution
of regulatory proteins in the nucleus, it is probable that the mech-
anisms necessary for maintaining genes or group of genes in a
repressed state will differ between TADs located within the nuclear
interior and TADs located close to the nuclear periphery, in partic-
ular those attached to the nuclear matrix and corresponding to
LADs. In such view, the link between chromatin state and nuclear
positioning remains to be better understood. It will be important
to determine the role of the nuclearmatrix, not only nuclear lamina,
but also the internal ﬁbrillar components of the ‘‘nucleoskeleton’’,
in maintaining the boundaries between chromosome domains
and in organizing their interactions within the nuclear space.
Although the topological organization of the genome in TADs
and sub-domains appears to play a role in transcriptional response,
those models are constructed from correlations. Future compre-
hensive understanding on the relation between expression and
structure will require functional testing by genome engineering.
In particular, CRISPR/Cas9 methodology [64] will permit to charac-
terize the consequences of deletion or generation of topological
borders. In addition, these methods will serve to modify the natu-
ral location of genes and determine the consequences on their
expression and response to external cues. In particular it will be
important to analyze the behavior of genes normally
non-responding to steroids when introduced within a domain on
which hormones have a more general effect. Such experiments will
permit to understand the mode of actions of enhancers, regulatory
elements and insulators. Finally, it is important to keep in mind
that structural data obtained by Hi-C are averages of structures
occurring within the cell population (see Junier et al., this issue
for further reading on those aspects). It will be essential to com-
plete this view with single cell analysis to determine whether
the apparent changes induced by hormones are reﬂecting the tran-
sition from one structure to another in single cells or rather
changes of the proportions of already established structures within
the cell population. Answering this question will require
Fig. 4. Model of coordinated changes in gene expression upon progesterone. Within a Progestins-repressed TAD, prior to hormone treatment, long-range interactions with an
active enhancer maintain the transcription of the genes. Upon hormone exposure Progesterone Receptor-mediated modiﬁcations of chromatin or competition between the
Progesterone Receptor and other transcription factors destabilize those interactions, leading to the repression of the expression of the genes (R: Progestins repressed genes).
Conversely, within a Progestins-activated TAD, Progesterone Receptor binding favors the establishment or stabilization of long-range interactions between enhancer and
genes (R+: Progestins activated genes).
F. Le Dily, M. Beato / FEBS Letters 589 (2015) 2885–2892 2891complementing Hi-C experiments with high resolution microscopy
of 3D-FISH analysis.
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